Anti-ST3GAL6 monoclonal antibody

Pre-made anti-ST3GAL6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ST3GAL6/ST3GAL6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1828-Ab-1/ GM-Tg-hg-IP1828-Ab-2Anti-Human ST3GAL6 monoclonal antibodyHuman
GM-Tg-rg-IP1828-Ab-1/ GM-Tg-rg-IP1828-Ab-2Anti-Rat ST3GAL6 monoclonal antibodyRat
GM-Tg-mg-IP1828-Ab-1/ GM-Tg-mg-IP1828-Ab-2Anti-Mouse ST3GAL6 monoclonal antibodyMouse
GM-Tg-cynog-IP1828-Ab-1/ GM-Tg-cynog-IP1828-Ab-2Anti-Cynomolgus/ Rhesus macaque ST3GAL6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1828-Ab-1/ GM-Tg-felg-IP1828-Ab-2Anti-Feline ST3GAL6 monoclonal antibodyFeline
GM-Tg-cang-IP1828-Ab-1/ GM-Tg-cang-IP1828-Ab-2Anti-Canine ST3GAL6 monoclonal antibodyCanine
GM-Tg-bovg-IP1828-Ab-1/ GM-Tg-bovg-IP1828-Ab-2Anti-Bovine ST3GAL6 monoclonal antibodyBovine
GM-Tg-equg-IP1828-Ab-1/ GM-Tg-equg-IP1828-Ab-2Anti-Equine ST3GAL6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1828-Ab-1/ GM-Tg-hg-IP1828-Ab-2; GM-Tg-rg-IP1828-Ab-1/ GM-Tg-rg-IP1828-Ab-2;
GM-Tg-mg-IP1828-Ab-1/ GM-Tg-mg-IP1828-Ab-2; GM-Tg-cynog-IP1828-Ab-1/ GM-Tg-cynog-IP1828-Ab-2;
GM-Tg-felg-IP1828-Ab-1/ GM-Tg-felg-IP1828-Ab-2; GM-Tg-cang-IP1828-Ab-1/ GM-Tg-cang-IP1828-Ab-2;
GM-Tg-bovg-IP1828-Ab-1/ GM-Tg-bovg-IP1828-Ab-2; GM-Tg-equg-IP1828-Ab-1/ GM-Tg-equg-IP1828-Ab-2
Products NameAnti-ST3GAL6 monoclonal antibody
Formatmab
Target NameST3GAL6
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ST3GAL6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1828-Ag-1Recombinant multi-species SIA10/ ST3GAL6/ SIAT10 protein


    Target information

    Target IDGM-IP1828
    Target NameST3GAL6
    Gene ID10402,54613,304023,699096,478535,101091552,444860,100062218
    Gene Symbol and Synonyms1700023B24Rik,SIAT10,ST3GAL6,ST3GALVI
    Uniprot AccessionQ9Y274,P61943,Q6H8M7
    Uniprot Entry NameSIA10_HUMAN,SIA10_RAT,SIA10_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000064225
    Target ClassificationN/A

    The target: ST3GAL6, gene name: ST3GAL6, also named as SIAT10, ST3GALVI. The protein encoded by this gene is a member of the sialyltransferase family. Members of this family are enzymes that transfer sialic acid from the activated cytidine 5'-monophospho-N-acetylneuraminic acid to terminal positions on sialylated glycolipids (gangliosides) or to the N- or O-linked sugar chains of glycoproteins. This protein has high specificity for neolactotetraosylceramide and neolactohexaosylceramide as glycolipid substrates and may contribute to the formation of selectin ligands and sialyl Lewis X, a carbohydrate important for cell-to-cell recognition and a blood group antigen. [provided by RefSeq, Apr 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.